Question 1

What is this medicine for, and how does it work?

Accepted Answer

This is a recombinant coagulation factor. It activates the blood clotting process. It is used to control bleeding in hemophilia patients.

Question 2

When and how should this medicine be taken?

Accepted Answer

• For IV use only • Must be reconstituted before use • Give immediately after preparation

Question 3

When should this medicine not be used?

Accepted Answer

• Do not use if you have severe bleeding • Use with caution if you have history of thrombosis • Do not use if you have DIC

Question 4

What precautions should be taken before using this medicine?

Accepted Answer

• Use carefully in patients with blood clotting disorders • Monitor for signs of abnormal blood clotting • Use with caution in patients with liver disease • Not recommended during pregnancy or breastfeeding

Question 5

Is it safe to use this medicine during pregnancy?

Accepted Answer

• Limited data available; • Use with caution; • Consult doctor before use

Question 6

Can this medicine be used while breastfeeding?

Accepted Answer

• Use carefully in patients with blood clotting disorders • Monitor for signs of abnormal blood clotting • Use with caution in patients with liver disease • Not recommended during pregnancy or breastfeeding

Question 7

What should be done if a dose is missed?

Accepted Answer

• If you miss a dose, take it as soon as you remember. • However, if it's almost time for your next dose, skip the missed dose. • Never take two doses together. • For once-daily dosing: If you remember on the same day, take the dose. • Take your next dose at the regular time. • If you miss multiple doses, contact your doctor. • It's very important to take this medication at the correct time.

Question 8

What should be done in case of an overdose?

Accepted Answer

• Overdose symptoms: Thrombotic events. • Treatment: Monitor for thrombosis, supportive care.

Question 9

What should be done if side effects are experienced?

Accepted Answer

• Common side effects: Nausea, blood pressure changes, fever, headache • What to do: Close monitoring during treatment; Report unusual bleeding; Check vital signs; Stop taking the medication and seek medical advice if any severe side effect or unusual symptoms occur.

Question 10

What is Novoseven 200IU 1mg (5kiu) used for?

Accepted Answer

Novoseven 200IU 1mg (5kiu) (Eptacog Alfa) is a pharmaceutical medicine manufactured by Novo Nordisk in Bangladesh. It is primarily prescribed for Bleeding Episodes, Hemophilia.

Question 11

What is the active generic component of Novoseven 200IU?

Accepted Answer

The active ingredient in Novoseven 200IU is Eptacog Alfa, belonging to the Anti-Fibrinolytic Drugs drug class.

Question 12

What is the retail price of Novoseven 200IU 1mg (5kiu) in Bangladesh?

Accepted Answer

The official retail price of Novoseven 200IU 1mg (5kiu) (Injection) is ৳81200.00 in Bangladesh (prices may vary slightly by pack size and authorized pharmacy).

Question 13

What is the recommended dosage for Novoseven 200IU?

Accepted Answer

Standard adult dosage: Intravenous – Initially, 90 mcg/kg (initially every 2-3 hours). Pediatric dosage: Intravenous bolus – 90 mcg/kg (Every 2–3 hours). Always consult a registered physician for individualized dosage adjustments based on clinical assessment.

Question 14

Is Novoseven 200IU safe during pregnancy and breastfeeding?

Accepted Answer

Novoseven 200IU is classified under Pregnancy Category "C". Always consult your healthcare provider or OB/GYN before taking this medication during pregnancy or lactation.

Question 15

What are the common side effects of Novoseven 200IU?

Accepted Answer

Nausea; vomiting; skin reactions; fever; headache and changes in BP; Rarely; anaphylaxis;

Clinical Information	Administration Information
Indication: Bleeding episodes in patients with haemophilia Age: Adult	Dose: Intravenous – Initially, 90 mcg/kg Frequency: initially every 2-3 hours Duration: up to 3 weeks or more in cases of serious bleeding episodes Note: Given via intravenous bolus over 2-5 minutes. Additional dose may be given as needed to achieve or maintain haemostasis. May adjust dose or dosing interval according to response.
Indication: Bleeding episodes due to surgery or invasive procedures in patients with factor VII deficiency Age: Adult	Dose: Intravenous – 15-30 mcg/kg Frequency: every 4-6 hours Note: Given via intravenous bolus over 2-5 minutes until haemostasis is achieved.

Clinical Information	Administration Information
Indication: Congenital hemophilia A or B with inhibitors, acquired hemophilia, or Glanzmann's thrombasthenia	Dose: Intravenous bolus – 90 mcg/kg Frequency: Every 2–3 hours Duration: until hemostasis is achieved
Indication: Congenital Factor VII deficiency	Dose: Intravenous bolus – 15–30 mcg/kg Frequency: Every 4–6 hours Duration: until hemostasis is achieved

Drug Name	Risk Factors
Coagulation factor concentrates	Risk of potential drug interaction unknown
Prothrombin complex concentrates, activated or not	Avoid simultaneous use

Disease Name	Risk Factors
Hypersensitivity to Components	Risk of severe allergic reaction
Hypersensitivity to Mouse Protein	Risk of allergic reaction

Medicine Overview

Indication

What is this medicine for, and how does it work?

When and how should this medicine be taken?

When should this medicine not be used?

What precautions should be taken before using this medicine?

Is it safe to use this medicine during pregnancy?

Can this medicine be used while breastfeeding?

What should be done if a dose is missed?

What should be done in case of an overdose?

What should be done if side effects are experienced?

Adult Dose

Child Dose

Drug Interaction

Disease Interaction

Pregnancy

Data Sources